• Home
  • Pharmacology Series Session 3: COVID-19 Treatment, Research, and Guidelines by Christina Koutsari, Pharm.D, PH,D, BCPS, BCIDP

Pharmacology Series Session 3: COVID-19 Treatment, Research, and Guidelines by Christina Koutsari, Pharm.D, PH,D, BCPS, BCIDP

  • 3 Mar 2022
  • 6:30 PM - 7:30 PM
  • 275

Registration


Registration is closed

Topic:  COVID-19 Treatment, Research, and Guidelines

Speaker: Christina Koutsari, Pharm.D, PH,D, BCPS, BCID

Learner Outcomes:  

1. Improved understanding of current COVID-19 treatment guidelines.

2. Identify at least two therapeutic agents currently under investigation to manage and/or treat patients with COVID-19.

Cost: $15.00 USD

ANCC credits will only be given to participants who attend the virtual session on the date and time it is offered. This activity provides 1.00 ANCC contact hours, which includes 1.00 pharmacotherapeutic contact hours.

No conflict of interest was identified for anyone with the ability to control content of this virtual session.

This session is jointly provided by MN NACNS and the M Health Fairview Provider Unit. M Health Fairview is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

 




The Minnesota Affiliate of the National Association of Clinical Nurse Specialists is a 501(c)6 non-profit organization. 

Powered by Wild Apricot Membership Software